Royal Bank Of Canada Dare Bioscience, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.29 - $0.53 $155 - $283	535 New	535 $0
Q2 2023 Aug 14, 2023	BUY	$0.91 - $1.05 $347 - $401	382 New	382 $0
Q3 2022 Nov 14, 2022	BUY	$1.04 - $12.48 $16 - $199	16 New	16 $0
Q3 2021 Nov 15, 2021	SELL	$1.42 - $2.0 $71 - $100	-50 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.21 - $1.89 $60 - $94	50 New	50 $0

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $271M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.